3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Lymphoid
1
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Lymphoma, Follicular
3
Lymphoma
3
Lymphoma, Non-Hodgkin
2
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Multiple Myeloma
1
Melanoma
1
Lymphoproliferative Disorders
1
Lymphomatoid Granulomatosis
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Kidney Neoplasms
1
Influenza, Human
1
Epstein-Barr Virus Infections
1
Breast Neoplasms
1
Blast Crisis
1
Interventions
Filgrastim
5
fludarabine phosphate
4
Cyclophosphamide
4
Antilymphocyte Serum
4
Mycophenolic Acid
3
Carboplatin
3
pembrolizumab
2
Tacrolimus
2
Sirolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Paclitaxel
2
Methotrexate
2
Drug Therapy
2
Cyclosporine
2
Busulfan
2
valspodar
1
tremelimumab
1
thymoglobulin
1
temsirolimus
1
tanespimycin
1
sargramostim
1
poly ICLC
1
liposomal doxorubicin
1
ixabepilone
1
interferon-alfa-1b
1
glutamic acid diethyl ester
1
fludarabine
1
etoposide phosphate
1
durvalumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Interferons
×
Lymphoid
×
Clear all
NCT00276536
2015-10-14
IFNa
The Cleveland Clinic
Phase 1
Completed
35 enrolled